Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Advaxis, Inc. | 4,087,500 | reported | 01 Mar 2024 | tx 6+7,500,000−7,500,000 |
| Ayala Pharmaceuticals, Inc. | 0 | reported | 12 May 2020 | tx 5+805,988−1,161,976 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Mar 2024 | EXERCISE | Advaxis, Inc. | 3,750,000 | — | deriv |
| 01 Mar 2024 | EXERCISE | Advaxis, Inc. | 3,750,000 | — | deriv |
| 01 Mar 2024 | EXERCISE | Advaxis, Inc. | 2,250,000 | — | deriv |
| 01 Mar 2024 | EXERCISE | Advaxis, Inc. | 1,500,000 | — | deriv |
| 01 Mar 2024 | EXERCISE | Advaxis, Inc. | 2,250,000 | — | deriv |
| 01 Mar 2024 | EXERCISE | Advaxis, Inc. | 1,500,000 | — | deriv |
| 12 May 2020 | CONVERSION | Ayala Pharmaceuticals, Inc. | 369,231 | 0.00 USD | |
| 12 May 2020 | PURCHASE | Ayala Pharmaceuticals, Inc. | 225,000 | 15.00 USD | |
| 12 May 2020 | CONVERSION | Ayala Pharmaceuticals, Inc. | 211,757 | 0.00 USD | |
| 12 May 2020 | CONVERSION | Ayala Pharmaceuticals, Inc. | 423,514 | — | deriv |
| 12 May 2020 | CONVERSION | Ayala Pharmaceuticals, Inc. | 738,462 | — | deriv |